If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
7th Jan 20194:51 pmRNSTransaction in Own Shares
4th Jan 20195:14 pmRNSTransaction in Own Shares
4th Jan 201910:54 amRNSNet Asset Value(s)
3rd Jan 20194:58 pmRNSTransaction in Own Shares
2nd Jan 20195:17 pmRNSTransaction in Own Shares
31st Dec 20181:00 pmRNSTransaction in Own Shares
28th Dec 20185:05 pmRNSTransaction in Own Shares
28th Dec 201812:00 pmRNSNet Asset Value(s)
27th Dec 20185:02 pmRNSTransaction in Own Shares
27th Dec 201812:52 pmRNSNet Asset Value(s)
27th Dec 201811:41 amRNSTransaction in Own Shares
21st Dec 20185:25 pmRNSTransaction in Own Shares
20th Dec 20185:27 pmRNSTransaction in Own Shares
19th Dec 20185:22 pmRNSTransaction in Own Shares
18th Dec 20185:44 pmRNSTransaction in Own Shares
18th Dec 201810:56 amRNSNet Asset Value(s)
18th Dec 20187:00 amRNSTransaction in Own Shares
11th Dec 201811:16 amRNSNet Asset Value(s)
5th Dec 201811:33 amRNSNet Asset Value(s)
27th Nov 201811:38 amRNSNet Asset Value(s)
21st Nov 201812:50 pmRNSNet Asset Value(s)
20th Nov 201811:16 amRNSNet Asset Value(s)
15th Nov 201812:53 pmRNSSale of Shares from Treasury
14th Nov 20185:37 pmRNSTransaction in Own Shares
13th Nov 20183:14 pmRNSNet Asset Value(s)
13th Nov 201810:29 amRNSHolding(s) in Company
9th Nov 20183:21 pmRNSDirectorate Change
5th Nov 20181:23 pmRNSNet Asset Value(s)
30th Oct 201812:38 pmRNSNet Asset Value(s)
24th Oct 20184:06 pmRNSNet Asset Value(s)
23rd Oct 201812:11 pmRNSNet Asset Value(s)
16th Oct 201812:31 pmRNSNet Asset Value(s)
9th Oct 20181:00 pmRNSNet Asset Value(s)
3rd Oct 201812:43 pmRNSNet Asset Value(s)
27th Sep 20187:00 amRNSHalf Yearly Financial Report
25th Sep 201812:59 pmRNSNet Asset Value(s)
24th Sep 201812:45 pmRNSNet Asset Value(s)
18th Sep 201811:30 amRNSNet Asset Value(s)
11th Sep 201812:51 pmRNSNet Asset Value(s)
6th Sep 20182:50 pmRNSNet Asset Value(s)
28th Aug 201811:20 amRNSNet Asset Value(s)
22nd Aug 20183:46 pmRNSNet Asset Value(s)
22nd Aug 201810:58 amRNSStatement re: Liquidation of the AllBlue Funds
21st Aug 201812:22 pmRNSNet Asset Value(s)
14th Aug 20181:12 pmRNSNet Asset Value(s)
13th Aug 201810:20 amRNSHolding(s) in Company
7th Aug 201811:11 amRNSNet Asset Value(s)
3rd Aug 201812:04 pmRNSNet Asset Value(s)
2nd Aug 20184:41 pmRNSResult of AGM
31st Jul 20185:04 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.